Evidence map›Paper›PMID 27240197›Full record

ArticleNature biotechnology2016

An artificial niche preserves the quiescence of muscle stem cells and enhances their therapeutic efficacy.

Marco Quarta, Jamie O Brett, Rebecca DiMarco, Antoine De Morree, Stephane C Boutet, Robert Chacon, Michael C Gibbons, Victor A Garcia, James Su, Joseph B Shrager and 2 more

Abstract read
In one paragraph

Article in Nature biotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 197 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Marco QuartaDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
Jamie O BrettDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
Rebecca DiMarcoDepartment of Bioengineering, Stanford University, Stanford, California, USA.
Antoine De MorreeDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
Stephane C BoutetDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
Robert ChaconDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
Michael C GibbonsDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.ORCID 0000-0002-3039-9839
Victor A GarciaDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
James SuDepartment of Materials Science and Engineering, Stanford University, Stanford, California, USA.
Joseph B ShragerDivision of Thoracic Surgery, Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California, USA.
Sarah HeilshornDepartment of Materials Science and Engineering, Stanford University, Stanford, California, USA.
Thomas A RandoDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA.
Stanford University · USVA Palo Alto Health Care System · US

Funding

Wnt signaling in muscle stem cell agingP01AG036695 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI THOMAS A. RANDO · 2011 to 2026
$29.3M
RESBIO - the Technology Resource for Polymeric BiomaterialsP41EB001046 · NIBIB · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI KOHN, JOACHIM B. · 2003 to 2017
$17.0M
Stanford Training Program in Aging ResearchT32AG047126 · NIA · STANFORD UNIVERSITY · PI VYJEYANTHI S PERIYAKOIL, TONY WYSS-CORAY · 2014 to 2026
$4.3M
A New Muscle-Brain Axis Underlying the Cognitive Benefits of Physical ActivityR01AG047820 · NIA · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI RANDO, THOMAS A., WYSS-CORAY, TONY · 2013 to 2017
$3.5M
Notch Signaling and Satellite Cell ActivationR37AG023806 · NIA · STANFORD UNIVERSITY · PI RANDO, THOMAS A. · 2010 to 2019
$2.9M
The Function and Regulation of Pax3 in Muscle Stem CellsR01AR062185 · NIAMS · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI RANDO, THOMAS A. · 2011 to 2015
$1.5M
Notch Signaling and Satellite Cell ActivationR01AG023806 · NIA · STANFORD UNIVERSITY · PI RANDO, THOMAS A. · 2005 to 2009
$1.2M
Regulation of Muscle Fibrosis in Response to Injury and AgingI01BX002324 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI RANDO, THOMAS A. · 2014 to 2021
–
The Effect of Exercise on the Efficacy of Neural Innervation in the Treatment of Volumetric Muscle LossI21RX002234 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI RANDO, THOMAS A. · 2016 to 2017
–
Muscle Stem Cell Therapy for Volumetric Muscle LossI01RX001222 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI HUANG, NGAN F. · 2014 to 2023
–
BLRD VA I01 BX002324NIAMS NIH HHS R01 AR062185NIA NIH HHS P01 AG036695NIA NIH HHS R01 AG023806NIA NIH HHS R01 AG047820NIA NIH HHS R37 AG023806NIA NIH HHS T32 AG047126NIBIB NIH HHS P41 EB001046RRD VA I01 RX001222RRD VA I21 RX002234
6 · The paper itself

Abstract

A promising therapeutic strategy for diverse genetic disorders involves transplantation of autologous stem cells that have been genetically corrected ex vivo. A major challenge in such approaches is a loss of stem cell potency during culture. Here we describe an artificial niche for maintaining muscle stem cells (MuSCs) in vitro in a potent, quiescent state. Using a machine learning method, we identified a molecular signature of quiescence and used it to screen for factors that could maintain mouse MuSC quiescence, thus defining a quiescence medium (QM). We also engineered muscle fibers that mimic the native myofiber of the MuSC niche. Mouse MuSCs maintained in QM on engineered fibers showed enhanced potential for engraftment, tissue regeneration and self-renewal after transplantation in mice. An artificial niche adapted to human cells similarly extended the quiescence of human MuSCs in vitro and enhanced their potency in vivo. Our approach for maintaining quiescence may be applicable to stem cells isolated from other tissues.

Indexed as

AnimalsBatch Cell Culture TechniquesCells, CulturedMiceMice, Inbred C57BLMuscle ProteinsMyoblasts, SkeletalStem Cell NicheStem Cell TransplantationTissue PreservationTreatment OutcomeMuscle Proteins

Identifiers

PMID27240197
PMCPMC4942359
OpenAlexW2414677434

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.